Table 1.
Characteristics | Patients with premalignant lesions* (n = 78), n (%) | Patients with adenocarcinoma (n =16), n (%) | Patients with squamous cell carcinoma (n = 19), n (%) |
---|---|---|---|
Age | |||
Mean (SD) | 61.2 (10.0) | 60.1 (10.7) | 68.5 (7.4) |
Range | 33–78 | 40–80 | 52–80 |
Sex | |||
Female | 19 (24) | 6 (38) | 9 (47) |
Male | 59 (76) | 10 (62) | 10 (53) |
Race | |||
White | 103 (97) | 16 (100) | 11 (58) |
Black | 3 (3) | — | 8 (42) |
Smoking status | |||
Never | 2 (3) | 3 (19) | 1 (5) |
Former | 47 (60) | 10 (63) | 10 (53) |
Current | 29 (37) | 2 (13) | 5 (26) |
Unknown | — | 1 (6) | 3 (16) |
Previous lung cancer | |||
Yes | 16 (20) | — | — |
No | 62 (80) | ||
COPD | |||
Yes | 58 (74) | — | — |
No | 20 (26) | ||
Asbestos exposure | |||
Yes | 41 (53) | — | — |
No | 37 (47) | ||
Tumor stage | |||
I | — | 11 (69) | 7 (37) |
II | — | 6 (31) | |
III | 5 (31) | 5 (26) | |
Unknown | — | 1 (5) |
Abbreviation: COPD, chronic obstructive pulmonary disease.
Includes histologic diagnoses of metaplasia, mild dysplasia, moderate dysplasia, and severe dysplasia.